Thank you. I love this part because it highlights
Post# of 72440
Posted On: 02/22/2016 9:46:01 AM
Re: someconcerns #18883
Thank you.
I love this part because it highlights that these were sickly patients. Late stage patients without hope yet single doses resulted in some p21 data that point to efficacy... That is that Kevetrin is doing what it was expected to do.
Go Dr.Mennon!
“Now, this new p21 data only reinforces our high expectations for and confidence in Kevetrin, specifically, its potential to treat patients across a broad spectrum of cancer types and even those in late stages with refractory tumors"
I love this part because it highlights that these were sickly patients. Late stage patients without hope yet single doses resulted in some p21 data that point to efficacy... That is that Kevetrin is doing what it was expected to do.
Go Dr.Mennon!
“Now, this new p21 data only reinforces our high expectations for and confidence in Kevetrin, specifically, its potential to treat patients across a broad spectrum of cancer types and even those in late stages with refractory tumors"
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
Scroll down for more posts ▼